IS7811A - Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum - Google Patents
Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðumInfo
- Publication number
- IS7811A IS7811A IS7811A IS7811A IS7811A IS 7811 A IS7811 A IS 7811A IS 7811 A IS7811 A IS 7811A IS 7811 A IS7811 A IS 7811A IS 7811 A IS7811 A IS 7811A
- Authority
- IS
- Iceland
- Prior art keywords
- diseases
- treatment
- methods
- disorders associated
- increased levels
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41304002P | 2002-09-24 | 2002-09-24 | |
US41726102P | 2002-10-09 | 2002-10-09 | |
US42742402P | 2002-11-19 | 2002-11-19 | |
US42752602P | 2002-11-19 | 2002-11-19 | |
US46475303P | 2003-04-23 | 2003-04-23 | |
PCT/US2003/030156 WO2004030618A2 (en) | 2002-09-24 | 2003-09-24 | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7811A true IS7811A (is) | 2005-04-19 |
Family
ID=32074779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7811A IS7811A (is) | 2002-09-24 | 2005-04-19 | Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1553955A4 (zh) |
JP (1) | JP2006503905A (zh) |
AR (1) | AR041386A1 (zh) |
AU (1) | AU2003299196A1 (zh) |
BR (1) | BR0314713A (zh) |
CA (1) | CA2509526A1 (zh) |
HR (1) | HRP20050355A2 (zh) |
IS (1) | IS7811A (zh) |
MX (1) | MXPA05003152A (zh) |
NO (1) | NO20051669L (zh) |
TW (1) | TW200422042A (zh) |
WO (1) | WO2004030618A2 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05008649A (es) * | 2003-02-14 | 2005-11-23 | Combinatorx Inc | Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios. |
AU2004275777A1 (en) * | 2003-09-24 | 2005-04-07 | Combinatorx, Incorporated | Therapeutic regimens for administering drug combinations |
AU2005247403A1 (en) * | 2004-05-17 | 2005-12-08 | Combinatorx, Incorporated | Methods and reagents for the treatment of immunoinflammatory disorders |
BRPI0517847A (pt) * | 2004-11-19 | 2008-10-21 | Organon Nv | combinação, usos de um inibidor de reabsorção de serotonina seletiva e de um antagonista do receptor de glicocorticóide, e, método para o tratamento de um indivìduo de uma espécie vertebrada sofrendo de depressão ou um distúrbio relacionado |
AU2011236053B2 (en) * | 2004-11-19 | 2014-06-26 | Merck Sharpe & Dohme B.V. | Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression |
PL1719507T3 (pl) * | 2005-04-13 | 2010-12-31 | Cipher Pharmaceuticals Inc | Agoniści receptora beta2-adrenergicznego do leczenia chorób tkanki łącznej skóry |
JP4832806B2 (ja) * | 2005-06-03 | 2011-12-07 | 久光製薬株式会社 | 経皮投与製剤 |
TW200711649A (en) * | 2005-06-17 | 2007-04-01 | Combinatorx Inc | Combination therapy for the treatment of immunoinflammatory disorders |
EP2059234B1 (en) * | 2006-09-08 | 2011-11-02 | Ore Pharmaceuticals Inc. | Method for reducing or alleviating inflammation in the digestive tract |
US20080064709A1 (en) * | 2006-09-11 | 2008-03-13 | Duke University | Methods and compositions for the treatment of vascular depression |
GB0701171D0 (en) * | 2007-01-22 | 2007-02-28 | Imp Innovations Ltd | Compositions and uses thereof |
WO2010098230A1 (ja) * | 2009-02-27 | 2010-09-02 | 久光製薬株式会社 | 経皮投与製剤 |
PT117765A (pt) * | 2022-01-28 | 2023-07-28 | Faculdade De Farmacia Da Univ De Lisboa | Formulação tópica de fluvoxamina para o tratamento de psoríase |
TW202423434A (zh) * | 2022-10-07 | 2024-06-16 | 瑞士商歐庫利斯營運股份有限公司 | mTOR抑制劑的點眼劑微懸液 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69230862T2 (de) * | 1991-10-15 | 2000-12-14 | Michael F. Mullarkey | Rezeptoren zur Behandlung von Entzündungen vom verzögerten Typ |
GB9603137D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
ES2259746T3 (es) * | 1996-07-15 | 2006-10-16 | Alza Corporation | Nuevas formulaciones para la administracion transdermica de fluoxetina. |
SK122199A3 (en) * | 1997-03-18 | 2000-12-11 | Basf Ag | Methods and compositions for modulating responsiveness to corticosteroids |
US6281248B1 (en) * | 2000-02-16 | 2001-08-28 | Magda Abdel Fattah Ahmed | Composition for treating asthma |
IL139975A0 (en) * | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
-
2003
- 2003-09-24 CA CA002509526A patent/CA2509526A1/en not_active Abandoned
- 2003-09-24 WO PCT/US2003/030156 patent/WO2004030618A2/en active Application Filing
- 2003-09-24 AR ARP030103484A patent/AR041386A1/es unknown
- 2003-09-24 BR BR0314713-4A patent/BR0314713A/pt not_active IP Right Cessation
- 2003-09-24 JP JP2005500317A patent/JP2006503905A/ja active Pending
- 2003-09-24 TW TW092126503A patent/TW200422042A/zh unknown
- 2003-09-24 AU AU2003299196A patent/AU2003299196A1/en not_active Abandoned
- 2003-09-24 MX MXPA05003152A patent/MXPA05003152A/es not_active Application Discontinuation
- 2003-09-24 EP EP03756864A patent/EP1553955A4/en not_active Withdrawn
-
2005
- 2005-04-04 NO NO20051669A patent/NO20051669L/no not_active Application Discontinuation
- 2005-04-19 IS IS7811A patent/IS7811A/is unknown
- 2005-04-19 HR HR20050355A patent/HRP20050355A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1553955A4 (en) | 2008-11-05 |
HRP20050355A2 (en) | 2005-10-31 |
MXPA05003152A (es) | 2006-04-27 |
WO2004030618A3 (en) | 2005-04-07 |
JP2006503905A (ja) | 2006-02-02 |
NO20051669L (no) | 2005-06-10 |
WO2004030618A2 (en) | 2004-04-15 |
AR041386A1 (es) | 2005-05-18 |
EP1553955A2 (en) | 2005-07-20 |
AU2003299196A1 (en) | 2004-04-23 |
TW200422042A (en) | 2004-11-01 |
CA2509526A1 (en) | 2004-04-15 |
BR0314713A (pt) | 2005-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7811A (is) | Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum | |
IS8451A (is) | Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma | |
CY2021009I1 (el) | Αντισωματα αντι-ρ-σελεκτινης και μεθοδοι χρησης αυτων στην αντιμετωπιση φλεγμονωδων νοσων | |
IS8410A (is) | Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma | |
DK1765322T3 (da) | Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser | |
IL183827A0 (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders | |
DK1889065T3 (da) | Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent | |
DE602004022347D1 (de) | Testeinrichtung und Testverfahren | |
IL200580A0 (en) | 2-phenoxy-and-2-phenylsulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders | |
DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
DK1755743T3 (da) | Beta-hydroxybutyrat og derivater til behandling af depression og angst | |
DE602005003186D1 (de) | Fluorkopolymer und dessen Verwendung | |
DK1951866T3 (da) | Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer | |
DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
DK2308507T3 (da) | Fremgangsmåder til behandling af præeklampsi | |
IS8497A (is) | Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma | |
DK1974017T3 (da) | Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler | |
PL381765A1 (pl) | Konstrukty wiążące i sposoby ich zastosowania | |
IL180251A0 (en) | Methods and reagents for the treatment of metabolic disorders | |
EP1902145A4 (en) | METHOD FOR DIAGNOSIS AND TREATMENT OF AN INFLAMMATORY REACTION | |
DK1701944T3 (da) | 2-(amino-substituerede)-4-aryl-pyramidiner og relaterede forbindelser til behandling af inflammationssygdomme | |
DK1952103T3 (da) | Fremgangsmåde til at veje med flere vejeceller | |
DE602005010151D1 (de) | Photoleitfähiges Bildherstellungselement und dessen Herstellungsverfahren | |
DK1896077T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme | |
DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme |